Summary of Classification and Labelling
General Information
EC / List no.
|
Name |
CAS Number
|
|---|---|---|
| 238-483-7 | Deflazacort | 14484-47-0 |
Notified classification and labelling according to CLP criteria
| Classification | Labelling | Specific Concentration limits, M-Factors | Notes | Classification affected by Impurities / Additives
|
Additional Notified Information
|
Number of Notifiers
|
Joint Entries
|
||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hazard Class and Category Code(s) | Hazard Statement Code(s) | Hazard Statement Code(s) | Supplementary Hazard Statement Code(s) | Pictograms, Signal Word Code(s) | |||||||
| Repr. 1A | H360 (H360Df) | H360 (Kann das Kind i...) |
GHS08 Dgr |
State/Form
|
24 | View details | |||||
| STOT RE 2 | H373 (other:unbekannt) | H373 | |||||||||
| STOT RE 2 | H373 (Endocrine syste...) | H373 |
GHS08 Wng |
State/Form
|
1 | View details | |||||
| STOT RE 2 | H373 (other:Endocrine...) | H373 | |||||||||
| Repr. 2 | H361 | H361 |
GHS08 Wng |
State/Form
|
1 | View details | |||||
| Repr. 2 | H361 (Suspected of da...) | H361 (Suspected of da...) |
GHS08 Wng |
State/Form
|
1 | View details | |||||
| Lact. | H362 | H362 | |||||||||
| STOT RE 2 | H373 (Not determined) | H373 | |||||||||
| Repr. 2 | H361 (Suspected of da...) | H361 (Suspected of da...) |
GHS08 Wng |
State/Form
|
1 | View details | |||||
| Lact. | H362 | H362 | |||||||||
| STOT RE 2 | H373 (endocrine syste...) | H373 | |||||||||
| Acute Tox. 4 | H312 | H312 |
GHS08 GHS07 Wng |
1 | View details | ||||||
| Skin Irrit. 2 | H315 | H315 | |||||||||
| Eye Irrit. 2 | H319 | H319 | |||||||||
| Acute Tox. 4 | H332 | H332 | |||||||||
| STOT SE 3 | H335 (other:not known) | H335 | |||||||||
| STOT SE 3 | H335 (not known) | H335 | |||||||||
| Repr. 2 | H361 | H361 | |||||||||
| Repr. 2 | H361 (Suspected of da...) | H361 |
GHS08 Wng |
State/Form
|
1 | View details | |||||
| Lact. | H362 | H362 | |||||||||
| STOT RE 2 | H373 (other:Not deter...) | H373 | |||||||||
Number of Aggregated Notifications: 7